• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Drug Research and Development
Drug Research and Development

...  Food and Drug Administration – is an agency within the US Department of Health and Human Services that regulates new drugs, vaccines, biologics, and devices  The Food and Drug Act of 1908 established the agency, and it has been strengthened many times, usually in response to a clinical safety pro ...
An overview of second  generation drugs  for photodynamic
An overview of second generation drugs for photodynamic

... been formulated into liposomes. In the case of zinc phthalocyanine a mulrilamela liposome formulation has been suggested while for BPD-MA a unilamella liposome formulation is being used. While liposomes have not yet found wide use in the pharmaceutical field due to their cost of large scale producti ...
powerpoint
powerpoint

... medicines are safe and effective before the Food and Drug Administration (FDA) allows them to sell their product. Scientists study the risks of each drug compared with the benefits. Drugs that carry low risks to health in comparison to their benefits are more desirable in the treatment of disease. ...
Lecture: Pharmacogenomics
Lecture: Pharmacogenomics

... SNPs Can Change Drug Response • Pharmacokinetic: changes in drug metabolism • Pharmacodynamic: changes in drug targets – enzymes, receptors, or transporters ...
ECSTASY
ECSTASY

... spasms, and convulsions. It can make you feel paranoid, hostile and anxious even when not high. It increases the rate of heart attack, stroke, seizure, and respiratory failure, any of which can result in sudden death. ...
Drug Facilitated Sexual Assault
Drug Facilitated Sexual Assault

... (Content areas reflective of current practice 7/16/09 – revise as appropriate to reflect current standards of care.) ...
What is Sanfilippo disease type C?
What is Sanfilippo disease type C?

... and hypertrichosis. There is no treatment but there are research efforts to find one funded primarily by multiple MPSIIIC disease foundations. The number of patients and research community engaged are both small. The amount of research funding available is limited so any efforts to raise awareness o ...
DRUGS TO TRY AND AVOID IN WARFARIN PATIENTS
DRUGS TO TRY AND AVOID IN WARFARIN PATIENTS

... warfarin. Patients already on any of these drugs may be started on warfarin and the dose adjusted as required. Drug interactions with warfarin tend to be variable and unpredictable and on the whole affect a fairly small proportion of patients. If any of the drugs below are to be started in these pat ...
week3pm
week3pm

... Estimates that there is a 10-year gap between medically relevant bio-technological advances and appropriate application, or translation into routine medical practice ...
22Jan2002 PAGE 1
22Jan2002 PAGE 1

... 45. It is felt that the newest version of the Diagnostic and Statistical Manual, DSM-IV, will be the final one. 46. A diagnosis of drug dependence in DSM-IV requires that tolerance and withdrawal be observed. 47. The initial introduction to Europe of tobacco, coffee, and tea was met with much celebr ...
Drug Induced Dementia
Drug Induced Dementia

... • Heavy machinery and driving cautions • Sedation and excitement ...
Overview - science of addiction
Overview - science of addiction

...  Social stigma sometimes blocks sensible policy-making and strategies that may result in progress when dealing with the drug abuse problem.  There have been remarkable advances in our understanding of addiction in the last two decades.  Researchers have worked out the mechanism of action of nearl ...
New Hampshire EMT-Intermediate Pharmacology
New Hampshire EMT-Intermediate Pharmacology

... Agonist: drug that binds to a receptor and causes it to initiate the expected response  Antagonist: drug that binds to a receptor but does not cause it to initiate the expected response ...
Benzodiazepine Fact Sheet
Benzodiazepine Fact Sheet

... physiologically habituated to the drug, and prone to serious withdrawal reactions, including potentially fatal epileptic seizures, if the drug is stopped suddenly. These reactions rarely if ever occur in low-dose medication treatments. Severe Intoxication — Extreme doses of medication — i.e. doses h ...
Commonly Abused Prescription and OTC Drugs
Commonly Abused Prescription and OTC Drugs

... medicines -- it helps stop the cough. But large doses can get you high and cause hallucinations. It's popular among teens, since cough syrup is so easy to find in medicine cabinets. High doses also cause vomiting, rapid heart rate, and -- rarely -- brain damage. Pseudoephedrine This is a decongestan ...
Pharmacokinetics
Pharmacokinetics

... extra layer of cells surrounding them (glial cells). However, fever/inflammation can make the membrane more permeable to other drugs ...
Drugs - North Allegheny School District
Drugs - North Allegheny School District

... Long term effects: Out-of-the-blue flashbacks – hallucinations without taking the drug again for up to a few days to a year after an acid trip. Severe depression All are illegal – PCP(angel dust) –considered to be one of the most dangerous of all drugs. Time seems to pass slowly, body movements s ...
File - Wk 1-2
File - Wk 1-2

...  Increasing plasma pH causes weakly acidic drugs to be extracted from the CNS into the plasma. The opposite is also true – by decreasing the plasma pH, weakly acidic drugs will become concentrated in the CNS, increasing their neurotoxicity 3. Describe the basic mechanisms of Phase I and Phase II re ...
Topics / Performance Enhancing Drugs / Performance Enhancing
Topics / Performance Enhancing Drugs / Performance Enhancing

... substances, including anti-inflammatory drugs, diuretics, and mega-doses of B-12 and other vitamins. She was banned from competition, but returned to sprinting after being reinstated in the 1990s. Performance-enhancing drugs have been used for centuries. Athletes in ancient Greece and Rome ingested ...
Pharmacology and the Nursing Process, 4th ed. Lilley/Harrington
Pharmacology and the Nursing Process, 4th ed. Lilley/Harrington

... FDA EVALUATES THE DATA FOR POSSIBLE APPROVAL FOLLOW-UP STUDIES POST MARKETING SURVEILLANCE ...
IN THE UNITED STATES DISTRICT COURT FOR
IN THE UNITED STATES DISTRICT COURT FOR

... drug establishment and that drug was not annually listed with the FDA by the establishment as one of the drugs which was being manufactured for commercial distribution in the United States at that drug establishment. 21 U.S.C. §§ 352(o), 360(o). Misbranded Drugs at Mohamed Basel Aswad, M.D. 10. In ...
Pharmaceutical pricing in France: a critique
Pharmaceutical pricing in France: a critique

... for more than 1% or 2 % of the total expenditure on pharmaceutical products in any given year. This is somewhere in the range of €500 million per annum, a sum which seems considerable in its own right. But it is still small, compared with the €25 billion that France spends on drugs every year. Such ...
Drugs on the brain
Drugs on the brain

... All drugs have side effects but new drugs aim to provide beneficial effects with minimal side effects ...
Amerge - Pinky S. Tiwari, MD, PA
Amerge - Pinky S. Tiwari, MD, PA

... Caution is also recommended in women after menopause or after removal of the ovaries, and men over 40 years old because of an increased risk for undiagnosed heart disease. ...
Chapter 7 - Drugs
Chapter 7 - Drugs

... may be found at a scene. The reference book gives a picture of the drug and states whether it is prescription, over-the-counter, or a controlled substance; it gives more detailed information about the drug as well. ...
< 1 ... 137 138 139 140 141 142 143 144 145 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report